Autopsy report · NCT04294888

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

“The study principle investigator left the institution.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Alzheimer Disease; Mild Cognitive Impairment; Aging

Interventions

repetitive transcranial magnetic stimulation (rTMS)

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
  “Principle investigator left the institution” (90% match in meaning)
• Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?
  “The researcher and principal investigator working on this study left the institution.” (86% match in meaning)
• Surgical Field Bacterial Contamination in Primary Total Hip (THA) and Knee (TKA) Arthroplasty
  “Study principal investigator left the organization” (83% match in meaning)
• Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
  “Investigator left institution and did not retain the study” (83% match in meaning)
• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.